A 63-Year-Old Woman With Metastatic EGFR-Mutated Non-Small Cell Lung Cancer

home / case-based-peer-perspectives / santos-castillero-egfr-nsclc

A 63-Year-Old Woman With Metastatic EGFR-Mutated Non-Small Cell Lung Cancer

Impressions of a Woman With EGFR+ Metastatic NSCLC

EP. 1: Impressions of a Woman With EGFR+ Metastatic NSCLC

March 25th 2020

Watch

Current Molecular Testing Strategies for EGFR+ NSCLC

EP. 2: Current Molecular Testing Strategies for EGFR+ NSCLC

March 25th 2020

Watch

EGFR-TKIs in First-Line EGFR+ Metastatic NSCLC

EP. 3: EGFR-TKIs in First-Line EGFR+ Metastatic NSCLC

March 25th 2020

Watch

EGFR-VEGF Inhibition for First-Line EGFR+ mNSCLC Treatment

EP. 4: EGFR-VEGF Inhibition for First-Line EGFR+ mNSCLC Treatment

March 25th 2020

Watch

EGFR+ mNSCLC: Monitoring Treatment Response and Next Steps

EP. 5: EGFR+ mNSCLC: Monitoring Treatment Response and Next Steps

March 25th 2020

Watch

Future Directions in EGFR+ NSCLC

EP. 6: Future Directions in EGFR+ NSCLC

March 25th 2020

Watch